Inhibition of ERRα suppresses epithelial mesenchymal transition of triple negative breast cancer cells by directly targeting fibronectin.
about
miR-135a Inhibits the Invasion of Cancer Cells via Suppression of ERRα.Inverse agonist of estrogen-related receptor α suppresses the growth of triple negative breast cancer cells through ROS generation and interaction with multiple cell signaling pathwaysVisfatin is involved in promotion of colorectal carcinoma malignancy through an inducing EMT mechanism.Pterostilbene prevents AKT-ERK axis-mediated polymerization of surface fibronectin on suspended lung cancer cells independently of apoptosis and suppresses metastasis.MicroRNA-497 downregulation contributes to cell proliferation, migration, and invasion of estrogen receptor alpha negative breast cancer by targeting estrogen-related receptor alpha.Visfatin Triggers the Cell Motility of Non-Small Cell Lung Cancer via Up-Regulation of Matrix Metalloproteinases.Bisphenol A Increases the Migration and Invasion of Triple-Negative Breast Cancer Cells via Oestrogen-related Receptor Gamma.The estrogen-related receptors (ERRs): potential targets against bone loss.Estrogen-related receptor α participates transforming growth factor-β (TGF-β) induced epithelial-mesenchymal transition of osteosarcoma cells.Antimetastatic effects of cordycepin mediated by the inhibition of mitochondrial activity and estrogen-related receptor α in human ovarian carcinoma cells.IL-8 Is Involved in Estrogen-Related Receptor α-Regulated Proliferation and Migration of Colorectal Cancer Cells.Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision Medicine.Knockdown of Snail inhibits epithelial-mesenchymal transition of human laryngeal squamous cell carcinoma Hep-2 cells through the vitamin D receptor signaling pathway.Role of the extracellular matrix in cancer-associated epithelial to mesenchymal transition phenomenon.Matrine inhibits the invasive and migratory properties of human hepatocellular carcinoma by regulating epithelial‑mesenchymal transition.Novel endocrine therapeutic strategy in endometrial carcinoma targeting estrogen-related receptor α by XCT790 and siRNA
P2860
Q36030509-9BA1B72A-1C58-4A61-AE2B-7FFEEA2382ABQ37022223-E4E1AFEC-9CF5-4220-8CB5-D04DB5C49786Q37362660-14C8BF61-7282-4907-8D52-645B75A6B739Q37715844-F19277F3-E46A-4BA5-9757-2D1C45C22FAEQ38755956-4FCDC9DB-AF31-45F1-993C-67ED8192272AQ38768489-C0A60D21-490C-4754-9F5A-F56979CBA4B2Q38781377-FE25C582-31CB-4DA3-9CDE-F72C90411274Q38924886-6B980C9D-B0ED-4F7B-B266-6C062049489DQ39482832-141B7D27-BE04-4900-8FF2-8F57EEF52439Q41994386-9315C969-CED0-43C3-9BA4-DB0E3E8DC504Q47673769-BC44E2EC-B0B1-4B0D-897F-3E5C7D6BDB85Q47717137-B133B7D5-A49D-4E7F-B056-27B5BE064A4CQ47955638-89EF75BA-2399-44A3-9EF1-A20579F1D3AEQ48010288-0C2565D5-9EF8-4244-92FF-74A8D03AFEB6Q54977780-1A380302-0EBC-4A37-9E25-B4C91B1D84CEQ58790596-CCBB8DDE-F6F8-4D40-9E9D-583C0DCB14BE
P2860
Inhibition of ERRα suppresses epithelial mesenchymal transition of triple negative breast cancer cells by directly targeting fibronectin.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Inhibition of ERRα suppresses ...... irectly targeting fibronectin.
@ast
Inhibition of ERRα suppresses ...... irectly targeting fibronectin.
@en
type
label
Inhibition of ERRα suppresses ...... irectly targeting fibronectin.
@ast
Inhibition of ERRα suppresses ...... irectly targeting fibronectin.
@en
prefLabel
Inhibition of ERRα suppresses ...... irectly targeting fibronectin.
@ast
Inhibition of ERRα suppresses ...... irectly targeting fibronectin.
@en
P2093
P2860
P356
P1433
P1476
Inhibition of ERRα suppresses ...... irectly targeting fibronectin.
@en
P2093
Hong-Sheng Wang
Huan-Liang Liu
Lin-Lin Lu
Wei-Dong Wei
Wei-Ting Liang
Xiang-Ling Yang
Ying-Min Wu
P2860
P304
25588-25601
P356
10.18632/ONCOTARGET.4436
P407
P577
2015-06-26T00:00:00Z